Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says 2019-03-20 08:00
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China 2019-03-19 18:30
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S. 2019-03-19 08:09
Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology 2019-03-14 21:14
Innovent Announces 2018 Annual Results 2019-03-14 07:36
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA® 2019-03-13 17:00
Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment 2019-03-13 02:55
Groundbreaking Memory Research Shows Amazonian Plant Extract PTI-00703 Cat's Claw as Potent Inhibitor and Reducer of Both Brain Plaques and Tangles 2019-03-06 07:20
Dr. Mehmood Khan Named CEO of Life Biosciences 2019-03-05 03:47
Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology 2019-03-04 21:00
Cedrus' Head of Life Sciences, Ms. Kimberly Nearing invited to speak at the BIO CEO & Investor Conference in New York City 2019-03-04 09:00
3SBio and TLC Form Exclusive Partnership to Commercialize Two NanoX(TM) Products in Mainland China 2019-03-04 07:00
Galderma: New Data Reveals Benefits of Combining Oral and Topical Treatment in Patients With Severe Papulopustular Rosacea 2019-03-01 20:33
Rakuten Aspyrian Announces Name Change to Rakuten Medical 2019-03-01 14:10
Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China 2019-03-01 10:07
Ascletis Appoints Former MSD Global Vice President Dr. Zhengqing Li as Chief Medical Officer and President of R&D Greater China 2019-03-01 08:00
Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors 2019-03-01 07:15
Trianni, Inc. Announces Issuance of Patent in Japan 2019-02-28 21:00
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million 2019-02-26 08:23
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
1 186 187 188 189 190 229